Neurobiological and clinical effects of the antidepressant tianeptine
- PMID: 18072812
- DOI: 10.2165/00023210-200822010-00002
Neurobiological and clinical effects of the antidepressant tianeptine
Abstract
The precise neurobiological processes involved in depression are not clear, but it is recognized that numerous factors are involved, including changes in neurotransmitter systems and brain plasticity. Neuroplasticity refers to the ability of the brain to adapt functionally and structurally to stimuli. Impairment of neuroplasticity in the hippocampus, amygdala and cortex is hypothesized to be the mechanism by which cognitive function, learning, memory and emotions are altered in depression. The mechanisms underlying alterations in neuroplasticity are believed to relate to changes in neurotransmitters, hormones and growth factors. Structural changes in the hippocampus that have been proposed to be associated with depression include dendritic atrophy, reduced levels of cerebral metabolites, decreased adult neurogenesis (generation of new nerve cells) and reduced volume. Increased dendritic branching occurs in the basolateral nucleus of the amygdala. Reduced neuronal size and glial cell density occur in the prefrontal cortex. Clinically, tianeptine is an antidepressant effective in reducing symptoms of depression in mild to moderate-to-severe major depression, including over the long term. Tianeptine is also effective in alleviating the symptoms of depression-associated anxiety. It is generally well tolerated, with little sedation or cognitive impairment. The efficacy profile of tianeptine could be explained by its neurobiological properties observed in animal models. Tianeptine prevents or reverses stress-associated structural and cellular changes in the brain and normalizes disrupted glutamatergic neurotransmission. In particular, in the hippocampus, it prevents stress-induced dendritic atrophy, improves neurogenesis, reduces apoptosis and normalizes metabolite levels and hippocampal volume. Tianeptine also has beneficial effects in the amygdala and cortex and can reverse the effects of stress on neuronal and synaptic functioning. The neurobiological properties of tianeptine may provide an explanation not only for its antidepressant activity, but also for its anxiolytic effects in depressed patients and its lack of adverse effects on cognitive function and memory.
Similar articles
-
Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression.Drugs. 1995 Mar;49(3):411-39. doi: 10.2165/00003495-199549030-00007. Drugs. 1995. PMID: 7774514 Review.
-
The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation.Mol Psychiatry. 2010 Mar;15(3):237-49. doi: 10.1038/mp.2009.80. Epub 2009 Aug 25. Mol Psychiatry. 2010. PMID: 19704408 Free PMC article. Review.
-
Neurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptine.Mol Psychiatry. 2005 Jun;10(6):525-37. doi: 10.1038/sj.mp.4001648. Mol Psychiatry. 2005. PMID: 15753957 Review.
-
The same antidepressant elicits contrasting patterns of synaptic changes in the amygdala vs hippocampus.Neuropsychopharmacology. 2012 Nov;37(12):2702-11. doi: 10.1038/npp.2012.135. Epub 2012 Jul 25. Neuropsychopharmacology. 2012. PMID: 22828748 Free PMC article.
-
Molecular mechanisms of neuroplasticity and pharmacological implications: the example of tianeptine.Eur Neuropsychopharmacol. 2004 Dec;14 Suppl 5:S497-502. doi: 10.1016/j.euroneuro.2004.09.008. Eur Neuropsychopharmacol. 2004. PMID: 15550348 Review.
Cited by
-
miR-7 controls glutamatergic transmission and neuronal connectivity in a Cdr1as-dependent manner.EMBO Rep. 2024 Jul;25(7):3008-3039. doi: 10.1038/s44319-024-00168-9. Epub 2024 Jun 3. EMBO Rep. 2024. PMID: 38831125 Free PMC article.
-
Usefulness of LDAEP to predict tolerability to SSRIs in major depressive disorder: a case report.Psychiatry Investig. 2012 Mar;9(1):80-2. doi: 10.4306/pi.2012.9.1.80. Epub 2012 Jan 17. Psychiatry Investig. 2012. PMID: 22396689 Free PMC article.
-
Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders.Curr Pharm Des. 2009;15(14):1595-611. doi: 10.2174/138161209788168010. Curr Pharm Des. 2009. PMID: 19442176 Free PMC article. Review.
-
Development of Dibenzothiazepine Derivatives as Multifunctional Compounds for Neuropathic Pain.Pharmaceuticals (Basel). 2022 Mar 27;15(4):407. doi: 10.3390/ph15040407. Pharmaceuticals (Basel). 2022. PMID: 35455404 Free PMC article.
-
Effects of Tianeptine Treatment on Depression and Cognitive Function in Patients with Alzheimer's Disease: A 12-Month Retrospective Observational Study.J Alzheimers Dis. 2022;88(2):707-720. doi: 10.3233/JAD-215630. J Alzheimers Dis. 2022. PMID: 35694919 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical